Patents Assigned to DIAPIN THERAPEUTICS LLC
  • TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS
    Publication number: 20210315963
    Abstract: The present disclosure provides a method of treating NAFLD, NASH, and atherosclerosis, comprising administering glycine-containing tripeptide molecule, or a pharmaceutically acceptable salt thereof to a subject.
    Type: Application
    Filed: August 9, 2019
    Publication date: October 14, 2021
    Applicants: DIAPIN THERAPEUTICS, LLC, THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Oren ROM, Jifeng ZHANG, Ying ZHAO, Yuquing Eugene CHEN
  • Treatment of Type 2 Diabetes With FTY720
    Publication number: 20140107024
    Abstract: The present disclosure provides therapeutic methods for prevention and treatment of type-2 diabetes comprising administering to the subject an effective amount of FTY720 or an analog.
    Type: Application
    Filed: December 19, 2013
    Publication date: April 17, 2014
    Applicant: Diapin Therapeutics LLC
    Inventor: Zhongmin Ma
  • Treatment of Type 2 Diabetes With FTY720
    Publication number: 20130123172
    Abstract: The present disclosure provides therapeutic methods for prevention and treatment of type-2 diabetes comprising administering to the subject an effective amount of FTY720 or an analog.
    Type: Application
    Filed: December 20, 2012
    Publication date: May 16, 2013
    Applicant: DIAPIN THERAPEUTICS LLC
    Inventor: DIAPIN THERAPEUTICS LLC